These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 23929452)

  • 1. Evaluations of in vitro metabolism, drug-drug interactions mediated by reversible and time-dependent inhibition of CYPs, and plasma protein binding of MMB4 DMS.
    Hong SP; Lusiak BD; Burback BL; Johnson JD
    Int J Toxicol; 2013; 32(4 Suppl):75S-87S. PubMed ID: 23929452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative toxicokinetics of MMB4 DMS in rats, rabbits, dogs, and monkeys following single and repeated intramuscular administration.
    Hong SP; Gibbs ST; Kobs DJ; Hawk MA; Croutch CR; Osheroff MR; Johnson JD; Burback BL
    Int J Toxicol; 2013; 32(4 Suppl):38S-48S. PubMed ID: 23929448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption, distribution, metabolism, and excretion of 14C-MMB4 DMS administered intramuscularly to Sprague-Dawley rats and New Zealand White rabbits.
    Lusiak BD; Kobs DJ; Hong SP; Burback BL; Johnson JD
    Int J Toxicol; 2013; 32(4 Suppl):88S-98S. PubMed ID: 23929453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and pharmacokinetic/pharmacodynamic study of 1,1'-methylenebis{4-[(hydroxyimino)methyl] pyridinium} dimethanesulfonate in guinea pigs and rhesus macaques exposed to cyclosarin.
    Harvilchuck JA; Hong SP; Richey JS; Osheroff MR; Johnson JD
    Int J Toxicol; 2013; 32(4 Suppl):108S-17S. PubMed ID: 23929444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of MMB4 DMS in rats, rabbits, and dogs following a single IV administration.
    Hong SP; Gibbs ST; Kobs DJ; Osheroff MR; Johnson JD; Burback BL
    Int J Toxicol; 2013; 32(4 Suppl):30S-7S. PubMed ID: 23929447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo acetylcholinesterase reactivation in male guinea pigs and rhesus macaques following cyclosarin exposure and treatment with 1,1'-methylenebis{4-[(hydroxyimino)methyl] pyridinium} dimethanesulfonate.
    Harvilchuck JA; Hong SP; Richey JS; Osheroff MR; Johnson JD
    Int J Toxicol; 2013; 32(4 Suppl):99S-107S. PubMed ID: 23929454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Good manufacturing practice: manufacturing of a nerve agent antidote nanoparticle suspension.
    Clark AP; Dixon H; Cantu NL; Cabell LA; McDonough JA
    Int J Toxicol; 2013; 32(4 Suppl):5S-17S. PubMed ID: 23929446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MMB4 DMS nanoparticle suspension formulation with enhanced stability for the treatment of nerve agent intoxication.
    Dixon H; Clark AP; Cabell LA; McDonough JA
    Int J Toxicol; 2013; 32(4 Suppl):18S-29S. PubMed ID: 23929445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MMB4 DMS: cardiovascular and pulmonary effects on dogs and neurobehavioral effects on rats.
    Roche BM; Vinci TM; Hawk MA; Hassler CR; Pressburger DT; Osheroff MR; Ritchie GD; Burback BL
    Int J Toxicol; 2013; 32(4 Suppl):49S-58S. PubMed ID: 23929450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative toxicology studies in Sprague-Dawley rats, rhesus monkeys, and New Zealand White rabbits to determine a no observed adverse effect level for 1,1'-methylenebis[4-[(hydroxyimino)methyl]-pyridinium] dimethanesulfonate.
    Osheroff MR; Kobs DJ; Buccellato M; Croutch CR; Elcock LE; Burback BL; Johnson JD
    Int J Toxicol; 2013; 32(4 Suppl):59S-74S. PubMed ID: 23929451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of acetylcholinesterase oxime-type reactivators K-48 and HI-6 on human liver microsomal cytochromes P450 in vitro.
    Veinlichova A; Jancova P; Siller M; Anzenbacher P; Kuca K; Jun D; Fusek J; Anzenbacherova E
    Chem Biol Interact; 2009 Aug; 180(3):449-53. PubMed ID: 19539805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct and metabolism-dependent cytochrome P450 inhibition assays for evaluating drug-drug interactions.
    Lee KS; Kim SK
    J Appl Toxicol; 2013 Feb; 33(2):100-8. PubMed ID: 21915887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of an in vitro, seven-in-one human cytochrome P450 assay for evaluation of both direct and time-dependent inhibition.
    Dahlinger D; Duechting S; Nuecken D; Sydow K; Fuhr U; Frechen S
    J Pharmacol Toxicol Methods; 2016; 77():66-75. PubMed ID: 26528794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the human liver cytochrome P450 isoenzymes responsible for the 5-methylhydroxylation of the novel anti-fibrotic drug AKF-PD.
    He X; Luo X; Liu Z; Hu G; Cheng Z
    Xenobiotica; 2011 Oct; 41(10):844-50. PubMed ID: 21679010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An in vitro evaluation of the victim and perpetrator potential of the anticancer agent laromustine (VNP40101M), based on reaction phenotyping and inhibition and induction of cytochrome P450 enzymes.
    Nassar AE; King I; Paris BL; Haupt L; Ndikum-Moffor F; Campbell R; Usuki E; Skibbe J; Brobst D; Ogilvie BW; Parkinson A
    Drug Metab Dispos; 2009 Sep; 37(9):1922-30. PubMed ID: 19520774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desvenlafaxine and venlafaxine exert minimal in vitro inhibition of human cytochrome P450 and P-glycoprotein activities.
    Oganesian A; Shilling AD; Young-Sciame R; Tran J; Watanyar A; Azam F; Kao J; Leung L
    Psychopharmacol Bull; 2009; 42(2):47-63. PubMed ID: 19629022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species differences in the metabolism of ritobegron in vitro and assessment of potential interactions with transporters and cytochrome P450 enzymes.
    Abe Y; Ota E; Harada H; Kanbe H; Kojima Y; Kanazawa T; Endo T; Murakami M; Kobayashi M
    Pharmazie; 2015 Jan; 70(1):38-46. PubMed ID: 25975097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organophosphorothionate pesticides inhibit the bioactivation of imipramine by human hepatic cytochrome P450s.
    Di Consiglio E; Meneguz A; Testai E
    Toxicol Appl Pharmacol; 2005 Jun; 205(3):237-46. PubMed ID: 15922009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain-targeting delivery of MMB4 DMS using carrier-free nanomedicine CRT-MMB4@MDZ.
    Du Y; Gao J; Zhang H; Meng X; Qiu D; Gao X; Zheng A
    Drug Deliv; 2021 Dec; 28(1):1822-1835. PubMed ID: 34515590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.